ATU Sligo /ATU St Angela's

go

Development and control of medicines and medical devices / (Record no. 50486)

MARC details
000 -LEADER
fixed length control field 01416cam a22003614a 4500
001 - CONTROL NUMBER
control field 593838
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20210921175505.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 040826s2004 enk b 001 0 eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780853695677
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780853695677 :
Terms of availability No price
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0853695679
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)56593838
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Transcribing agency NLM
Modifying agency UKM
-- IXA
-- BAKER
-- MUQ
-- YDXCP
-- CGC
-- BTCTA
042 ## - AUTHENTICATION CODE
Authentication code pcc
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.19
Item number HAR
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Harman, Robin J.
245 10 - TITLE STATEMENT
Title Development and control of medicines and medical devices /
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. London ;
-- Chicago :
Name of publisher, distributor, etc. Pharmaceutical Press,
Date of publication, distribution, etc. 2004.
300 ## - PHYSICAL DESCRIPTION
Extent xiii, 258 p. ;
Dimensions 26 cm.
336 ## - CONTENT TYPE
Content type term text
Source rdacontent
337 ## - MEDIA TYPE
Media type term unmediated
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term volume
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
520 8# - SUMMARY, ETC.
Summary, etc. This new title describes the tests and processes undertaken to bring new medicines and medical devices to the market, and the work of the government agencies which ensure products of the highest standard. The text covers the controls to prove quality, safety, and efficacy prior to marketing, and postmarketing pharmacovigilance requirements.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug development.
9 (RLIN) 32738
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical industry.
9 (RLIN) 2084
902 ## - LOCAL DATA ELEMENT B, LDB (RLIN)
a 151118
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN)
a .b10538306
b smmai
c -
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC 0
948 ## - LOCAL PROCESSING INFORMATION (OCLC); SERIES PART DESIGNATOR (RLIN)
h (OCLC) NO HOLDINGS IN LQI - 68 OTHER HOLDINGS
998 ## - LOCAL CONTROL INFORMATION (RLIN)
Operator's initials, OID (RLIN) 0
Cataloger's initials, CIN (RLIN) 081106
First Date, FD (RLIN) m
Local a
-- 0
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Cost, normal purchase price Total Checkouts Total Renewals Full call number Barcode Date last seen Copy number Cost, replacement price Price effective from Koha item type
    Other/Generic Classification Scheme     ATU Sligo Yeats Library ATU Sligo Yeats Library Main Lending Collection 06/11/2008 52.55 7 1 615.19 HAR 0051743 06/06/2017 1 52.55 06/06/2017 Standard Loan